Jermie E Cozart
Examiner (ID: 17502, Phone: (571)272-4528 , Office: P/3726 )
Most Active Art Unit | 3726 |
Art Unit(s) | 3728, 3799, 3726 |
Total Applications | 2110 |
Issued Applications | 1676 |
Pending Applications | 108 |
Abandoned Applications | 326 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17290887
[patent_doc_number] => 20210386726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => METHOD FOR INHIBITING CORONAVIRUS INFECTION AND REPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/006169
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/006169 | METHOD FOR INHIBITING CORONAVIRUS INFECTION AND REPLICATION | Aug 27, 2020 | Abandoned |
Array
(
[id] => 17290886
[patent_doc_number] => 20210386725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => METHOD FOR INHIBITING CORONAVIRUS INFECTION AND REPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/006103
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/006103 | METHOD FOR INHIBITING CORONAVIRUS INFECTION AND REPLICATION | Aug 27, 2020 | Abandoned |
Array
(
[id] => 18200848
[patent_doc_number] => 11583216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Method of administering sotalol IV/switch
[patent_app_type] => utility
[patent_app_number] => 17/003297
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 7467
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/003297 | Method of administering sotalol IV/switch | Aug 25, 2020 | Issued |
Array
(
[id] => 18084335
[patent_doc_number] => 11534442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Treatment of adipocytes
[patent_app_type] => utility
[patent_app_number] => 16/997447
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20044
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997447
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997447 | Treatment of adipocytes | Aug 18, 2020 | Issued |
Array
(
[id] => 17974291
[patent_doc_number] => 11491128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Reversible nitroxide derivatives of nitroalkenes that mediate nitrosating and alkylating reactions
[patent_app_type] => utility
[patent_app_number] => 16/995594
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 10796
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16995594
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/995594 | Reversible nitroxide derivatives of nitroalkenes that mediate nitrosating and alkylating reactions | Aug 16, 2020 | Issued |
Array
(
[id] => 18127978
[patent_doc_number] => 11554174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Methods for improved protection and delivery of aminothiols and analogs thereof
[patent_app_type] => utility
[patent_app_number] => 16/988239
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 15
[patent_no_of_words] => 25302
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988239
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/988239 | Methods for improved protection and delivery of aminothiols and analogs thereof | Aug 6, 2020 | Issued |
Array
(
[id] => 17875500
[patent_doc_number] => 11447501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Biphenyl-containing diarylpyrimido compounds, pharmaceutically-acceptable salts thereof, composition and preparation thereof
[patent_app_type] => utility
[patent_app_number] => 16/986200
[patent_app_country] => US
[patent_app_date] => 2020-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7426
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986200
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986200 | Biphenyl-containing diarylpyrimido compounds, pharmaceutically-acceptable salts thereof, composition and preparation thereof | Aug 4, 2020 | Issued |
Array
(
[id] => 16450888
[patent_doc_number] => 20200360314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF PAIN USING CAPSAICIN
[patent_app_type] => utility
[patent_app_number] => 16/984384
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984384 | Methods and compositions for treatment of pain using capsaicin | Aug 3, 2020 | Issued |
Array
(
[id] => 18273688
[patent_doc_number] => 11612609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Uses of oxygenated cholesterol sulfates (OCS)
[patent_app_type] => utility
[patent_app_number] => 16/983492
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 21608
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/983492 | Uses of oxygenated cholesterol sulfates (OCS) | Aug 2, 2020 | Issued |
Array
(
[id] => 16655928
[patent_doc_number] => 20210052564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => USE OF PANTOPRAZOLE IN PREVENTION AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/983955
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983955
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/983955 | USE OF PANTOPRAZOLE IN PREVENTION AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE | Aug 2, 2020 | Abandoned |
Array
(
[id] => 19135567
[patent_doc_number] => 11970497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Tricyclic AKR1C3 dependent KARS inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/973836
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 46979
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973836
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973836 | Tricyclic AKR1C3 dependent KARS inhibitors | Jul 30, 2020 | Issued |
Array
(
[id] => 16435628
[patent_doc_number] => 20200352953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/938247
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938247
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938247 | COMPOSITIONS AND METHODS FOR TREATING AN INFECTION | Jul 23, 2020 | Pending |
Array
(
[id] => 18716462
[patent_doc_number] => 11793783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Compositions and methods for treating an infection
[patent_app_type] => utility
[patent_app_number] => 16/938228
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54996
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938228
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938228 | Compositions and methods for treating an infection | Jul 23, 2020 | Issued |
Array
(
[id] => 16435565
[patent_doc_number] => 20200352890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => REVERSIBLY PROTECTED THIOLATED ELECTROPHILIC FATTY ACIDS AS PRODRUGS
[patent_app_type] => utility
[patent_app_number] => 16/937263
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16937263
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/937263 | REVERSIBLY PROTECTED THIOLATED ELECTROPHILIC FATTY ACIDS AS PRODRUGS | Jul 22, 2020 | Abandoned |
Array
(
[id] => 17874361
[patent_doc_number] => 11446353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Compositions and methods for the treatment of fungal infections
[patent_app_type] => utility
[patent_app_number] => 16/921610
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 6485
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921610
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/921610 | Compositions and methods for the treatment of fungal infections | Jul 5, 2020 | Issued |
Array
(
[id] => 16718497
[patent_doc_number] => 20210085644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => TREATMENT FOR PRIMARY BILIARY CHOLANGITIS
[patent_app_type] => utility
[patent_app_number] => 16/919404
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919404
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919404 | TREATMENT FOR PRIMARY BILIARY CHOLANGITIS | Jul 1, 2020 | Abandoned |
Array
(
[id] => 16822565
[patent_doc_number] => 20210137858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => COMBINATION FORMULATION CONTAINING COLCHICINE FOR TREATMENT OR ENHANCING THE THERAPY OF LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/914276
[patent_app_country] => US
[patent_app_date] => 2020-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16914276
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/914276 | COMBINATION FORMULATION CONTAINING COLCHICINE FOR TREATMENT OR ENHANCING THE THERAPY OF LIVER DISEASE | Jun 26, 2020 | Abandoned |
Array
(
[id] => 16539258
[patent_doc_number] => 20200405671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHODS AND MATERIALS FOR TREATING POLYCYSTIC KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/911932
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16911932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/911932 | METHODS AND MATERIALS FOR TREATING POLYCYSTIC KIDNEY DISEASE | Jun 24, 2020 | Abandoned |
Array
(
[id] => 16523710
[patent_doc_number] => 20200397790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => Uridine Phosphorylase (UPase) Inhibitors for Treatment of Liver Conditions
[patent_app_type] => utility
[patent_app_number] => 16/904262
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904262
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904262 | Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions | Jun 16, 2020 | Issued |
Array
(
[id] => 18027742
[patent_doc_number] => 11510902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Method for preventing or treating non-alcoholic fatty liver disease by antrodins
[patent_app_type] => utility
[patent_app_number] => 16/899587
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6446
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899587
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899587 | Method for preventing or treating non-alcoholic fatty liver disease by antrodins | Jun 11, 2020 | Issued |